Results 61 to 70 of about 2,527,653 (328)

Gemcitabine, Docetaxel, Melphalan, Carboplatin as Part of Sequential Cycles of High‐Dose Chemotherapy With Autologous Hematopoietic Stem‐Cell Rescue for Multiply Relapsed/Refractory Pediatric Germ Cell Tumors

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Although most malignant germ cell tumors (GCTs) are highly curable with cisplatin‐based therapy, options for patients with multiply relapsed/refractory disease remain limited. For this population, we report the first pediatric use of gemcitabine, docetaxel, melphalan, and carboplatin (GemDMC) as part of sequential cycles of high‐dose ...
Maria Frost   +10 more
wiley   +1 more source

Editorial Expression of Concern: Interferon-γ release assay

open access: yesMonaldi Archives for Chest Disease
The Publisher has been alerted to concerns about this article (DOI: 10.4081/monaldi.2025.3258), and an investigation is in progress. In the interim, we alert readers that these concerns have been raised.
The Publisher
doaj   +1 more source

South African Journal of Childhood Education authors and reviewers making an impact

open access: yesSouth African Journal of Childhood Education, 2023
No abstract available.
Elizabeth Henning
doaj   +1 more source

Do personality traits predict post-traumatic stress?: a prospective study in civilians experiencing air attacks [PDF]

open access: yes, 2005
Publisher version available from: http://journals.cambridge ...
Knezevic, G   +3 more
core   +1 more source

CPX‐351 in High‐Risk Relapsed Pediatric Acute Leukemia: Real‐World Phase 1 Data Establishing the FDA‐Approved Dose

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background/Objectives Outcomes for pediatric relapsed/refractory (R/R) acute myeloid leukemia (AML) remain dismal. CPX‐351, a liposomal formulation of cytarabine and daunorubicin, may have less off‐target toxicities than traditional chemotherapies and has shown improved outcomes for adults with newly diagnosed therapy‐related AML.
Jonathan D. Bender   +17 more
wiley   +1 more source

Do Entrepreneurs Matter? [PDF]

open access: yes, 2015
Publisher ...
Becker, Sascha O., Hvide, Hans Krogh
core  

An introduction to neural networks

open access: yes, 2018
From the Publisher: An Introduction to Nueral Networks will be warmly welcomed by a wide readership seeking an authoritative treatment of this key subject without an intimidating level of mathematics in the presentation.
Patrick van der Smagt, B. Krose
semanticscholar   +1 more source

Incidence and Risk Factors of Serious Osteonecrosis in Pediatric Acute Lymphoblastic Leukemia: A CYP‐C Population‐Based Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Osteonecrosis (ON) is a debilitating complication of acute lymphoblastic leukemia (ALL) therapy. While numerous studies have explored its incidence and associated risk factors, investigations using large‐scale cohorts remain important to characterize ON across heterogeneous populations.
Noémie de Villiers   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy